Status:

COMPLETED

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Lead Sponsor:

University of Washington

Collaborating Sponsors:

GlaxoSmithKline

Asociación Civil Impacta Salud y Educación, Peru

Conditions:

HIV Infections

Herpes Simplex

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

Over 80% of HIV-1 infected persons are also seropositive for HSV-2. Increasingly, clinical and epidemiologic evidence show the role of HSV in increasing HIV infectiousness. The evidence suggests that ...

Detailed Description

Conducted in Lima Peru, 20 HIV-1 and HSV-2 seropositive women with CD4 counts greater than 200 and on no antiretroviral therapy were randomly assigned to receive valacyclovir 500 mg bid or placebo for...

Eligibility Criteria

Inclusion

  • Greater than 18 years old woman,
  • Documented HIV-1 seropositive,
  • CD4 count greater than 200,
  • Not on HIV antiretroviral therapy,
  • HSV-2 seropositive as determined by Focus EIA (IN \>3.5)
  • Not intending to move out of the area for the duration of study participation.
  • Willing and able to:provide independent written informed consent;undergo clinical evaluations;take study drug as directed;adhere to follow-up schedule.
  • Bacterial STDs (symptomatic STD syndromes or laboratory-confirmed asymptomatic gonorrhea and syphilis) are treated within two weeks of study enrollment and random assignment.

Exclusion

  • Women who meet any of the following criteria are not eligible for this study:
  • Known history of adverse reaction to valacyclovir, acyclovir or famciclovir;
  • Planned open label use of acyclovir, valacyclovir, or famciclovir
  • Known medical history of seizures
  • Known renal failure, serum creatinine \>2.0mg/dl
  • Hematocrit \< 30 %

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00465205

Start Date

January 1 2005

End Date

December 1 2007

Last Update

August 22 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asociacion Civil Impacta Salud y Educacion

Lima, Peru

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons | DecenTrialz